Ginkgo Bioworks Partners with Inductive Bio and Tangible Scientific for AI-Driven Drug Discovery

Ginkgo Bioworks has announced a strategic partnership with Inductive Bio and Tangible Scientific to deploy AI-driven lab-in-the-loop workflows across the biopharma industry, announced in a press release. This collaboration aims to make AI-driven drug discovery more accessible by integrating high-throughput experimental workflows, streamlined compound management, and predictive chemistry AI models into a cohesive service.

The partnership leverages Ginkgo Datapoints' rapid ADME profiling, Inductive Bio's model-driven chemistry design platform, and Tangible Scientific's API-enabled compound management platform. This integration is designed to streamline the drug discovery process, reducing synthesis cycles and turnaround times while lowering overall costs.

By aligning design, experimentation, and data delivery into a single connected process, the partnership aims to enhance early-stage drug development efficiency. The services are now available for pharmaceutical and biotech teams seeking to improve ADMET optimization and reduce iteration times.